Preethi Sundaram - Chief Strategy Officer at Catalyst Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Strategy Officer
Stock Symbol
CPRX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Preethi Sundaram since 9/19/2023

Holdings reported by Preethi Sundaram for Catalyst Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 554K $626K $1.13 Feb 15, 2024 Direct Common Stock
Common Stock, par value $0.001 per share 25.5K $28.9K $1.13 Feb 15, 2024 Direct
Options to purchase common stock 557K Dec 8, 2023 Direct Common Stock

Transactions reported by Preethi Sundaram for Catalyst Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.